➡ 3D models of the intranasal airways of adults and children provide for inexpensive and rapid preclinical investigations into optimal formulation and device design for new nasal delivery products prior to expensive in vivo studies.
➡ 3D models of human intranasal airways allow for preclinical testing of factors that could affect the total and regional dose of new nasal delivery products under controlled conditions.
➡ 3D models of human intranasal airways can be used in preclinical testing of methods to optimize local, systemic and CNS delivery of new nasal products.
➡ The United States Pharmacopeia (USP) contains a number of General Chapters and General Information Chapters directly addressing key quality attributes required for components and delivery systems for inhalation drug products. The content and recent updates to General Chapters <5> and <601> will be reviewed covering inhalation drug product product quality and inhalation delivery systems performance quality tests respectively, followed by an overview of the inhalation performance quality tests contained in the General Information Chapters <1601> to <1604>.
➡ A new USP General Chapter <662> Metal Packaging Systems and Their Materials of Construction and its accompanying General Information Chapter <1662> are in the process of being developed to complete the series on primary packaging systems that currently covers glass containers <660> and plastics containers <661> for pharmaceutical use. Metal primary packaging materials are used in a wide variety of drug products including aluminum and stainless steel inhalation canisters. The presentation will provide an overview of progress to date in developing these two chapters that will include inhalation canisters.
➡ Exploring emerging trends and technologies in the field of inhalation drug delivery.
➡ Discussing the potential for cross-industry collaborations to drive innovation.
➡ Analyzing the impact of regulatory changes on the future of inhalation technology.
➡ Identifying opportunities for research and development in inhalation drug delivery.
14-15 November, 2024 | Manhattan, New York, USA